Search Within

NON-SMALL CELL LUNG CANCER
Results 1 - 227 of 227
Radiochemotherapy for Non Small Cell Lung Cancer

Journal: Current Drug Therapy
Volume: 5,Issue: 3
Page: 180-191
Authors: Orazio Caffo and Viviana Murgia

Molecular and Clinical Analysis of Predictive Biomarkers in Non-Small-Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 2
Page: 3689-3700
Authors: A. Passaro, A. Palazzo, P. Trenta, M. L. Mancini, F. Morano and E. Cortesi

Vinorelbine in the Treatment of Non-Small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 8
Page: 879-891
Authors: Cesare Gridelli and Rocco De. Vivo

Therapeutic Vaccines Explored in Patients with Non-Small Cell Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 2
Page: 256-264
Authors: Kui Ma and Ya H. Tang

Chemoradiotherapy in Locally Advanced, Unresectable Non-Small Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 4,Issue: 2
Page: 110-121
Authors: Lauren R. Mitchell, Jeffrey M. Albert and Bo Lu

The Role of Amitriptyline in the Management of Non-small Cell Lung Cancer

Journal: Current Cancer Therapy Reviews
Volume: 10,Issue: 3
Page: 284-288
Authors: John C. Ashton

Clinical Effectiveness and Cost-effectiveness of Target Therapies for Adult Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer: A Systematic Review

Journal: Current Cancer Drug Targets
Volume: 18,Issue: 5
Page: 405-409
Authors: Alessandra Bearz*, Massimiliano Berretta and Umberto Tirelli

Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 8
Page: 893-898
Authors: Enriqueta Felip and Rafael Rosell

Targeted Therapies for Non-Small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 2
Page: 2810-2831
Authors: G. S. Papaetis, C. Roussos and K. N. Syrigos

Chemotherapy of Non-small Cell Lung Cancer in Elderly Patients

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 1
Page: 1487-1495
Authors: C. Gridelli, P. Maione, G. Colantuoni and A. Rossi

Hypofractionated Radiotherapy in Non Small Cell Lung Cancer: A Review of the Current Literature

Journal: Reviews on Recent Clinical Trials
Volume: 5,Issue: 2
Page: 103-111
Authors: Beli I., Koukourakis G., Platoni K., Tolia M., Kelekis N., Kouvaris J., Syrigos C., Mystakidou K., Varveris C. and Kouloulias V.

Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 85-94
Authors: Tianhong Li, Primo N. Lara Jr., Philip C. Mack, Roman Perez-Soler, David R. Gandara, Gert van Assche, Severine Vermeire and Paul Rutgeerts

Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 5
Page: 646-650
Authors: Antonio Passaro, Daniele Alesini, Alessia Pochesci and Enrico Cortesi

Regulation Mechanism of MicroRNAs in Non-Small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 0
Page: 1-10
Authors: Feng-Yun Gong, Tao Bai, Ding-Yu Zhang*, Chao-lin Huang, Jing Lv, Jing-Li Wang, Xu-Dong Hu, Juan Wang and Wei Liu

The Role of Pemetrexed Combined with Gemcitabine for Non-Small-Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 61-66
Authors: Joanne Ngeow and Chee-Keong Toh

Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer: Update

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 1,Issue: 3
Page: 253-256
Authors: D. A. Arenberg

Angiogenesis and Angiogenic Inhibitors in Non Small Cell Lung Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 2
Page: 66-72
Authors: Nawfel Mellas, Zineb Benbrahim and Abdul Rahman Jazieh

Role of Pemetrexed and Platinums Combination in Patients with Non- Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 29-36
Authors: Manyin Chen, Wenlong Shao, Jianxing He and Daoyuan Wang

Molecular Modeling, Docking, Dynamics and Simulation of Gefitinib and its Derivatives with EGFR in Non-small Cell Lung Cancer

Journal: Current Computer-Aided Drug Design
Volume: 14,Issue: 0
Page: 1-7
Authors: Pulakuntla Swetha Reddy, Kiran Bharat Lokhande, Shuchi Nagar, Vaddi Damodara Reddy, P. Sushma Murthy and K. Venkateswara Swamy*

Chemoresistance in Non-Small Cell Lung Cancer

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 5,Issue: 1
Page: 73-88
Authors: Pascal Seve and Charles Dumontet

Small RNAs and Non-Small Cell Lung Cancer

Journal: Current Molecular Medicine
Volume: 6,Issue: 3
Page: 339-349
Authors: Alex W. Tong

The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 2-11
Authors: Krzysztof Konopa and Jacek Jassem

EGFR Mutation Testing in Non-Small Cell Lung Cancer

Journal: Current Respiratory Medicine Reviews
Volume: 6,Issue: 4
Page: 310-321
Authors: Krishna B. Sriram, Santiyagu M. Savarimuthu Francis, Maxine E. Tan, Rayleen V. Bowman, Ian A. Yang and Kwun M. Fong

EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11,Issue: 4
Page: 393-400
Authors: Ramon Andrade De Mello*, Davi J. J. Liu, Pedro N. Aguiar and Hakaru Tadokoro

The Roles of microRNAs in Regulating Chemotherapy Resistance of Non-Small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 0
Page: 1-6
Authors: Xiaoxuan Wei, Xiaoyan Shen, Yanchen Ren and Weidong Hu*

Selective Cyclooxygenase-2 Inhibitors and Non-small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 2
Page: 1851-1858
Authors: C. Gridelli, P. Maione, G. Airoma and A. Rossi

MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 6
Page: 694-700
Authors: Carmelo Tibaldi, Armida D’Incecco and Alessandro Lagana

Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 5
Page: 392-403
Authors: Ethan Amir, Sarah Hughes, Fiona Blackhall, Nick Thatcher, Gyula Ostoros, Jozsef Timar, Jozsef Tovari, Gabor Kovacs and Balazs Dome

Approaching the Increasing Complexity of Non-small Cell Lung Cancer Taxonomy

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 2
Page: 3973-3981
Authors: Marcello Maugeri-Sacca, Monica Bartucci, Alfredo Pagliuca, Michele Patrizii, Michele Signore and Ruggero De Maria

Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 2,Issue: 3
Page: 403-417
Authors: E.S. White, R.M. Strieter and D.A. Arenberg

Immunotherapy in Non-Small Cell Lung Cancer: Biological Principles and Future Opportunities

Journal: Current Molecular Medicine
Volume: 17,Issue: 8
Page: 527-540
Authors: M. Ilie, J. Benzaquen, V. Hofman, S. Lassalle, N. Yazbeck, S. Leroy, S. Heeke, C. Bence, B. Mograbi, N. Glaichenhaus, C.-H. Marquette and P. Hofman*

Stage N2/IIIA Non Small Cell Lung Cancer: An Evidence-Based Review

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 2
Page: 127-139
Authors: Christopher B. Komanapalli, Charles R. Thomas and Mithran S. Sukumar

Gene Expression Significance in Personalized Medicine of Non-small Cell Lung Cancer and Gene Expression Analyzing Platforms

Journal: Current Drug Metabolism
Volume: 12,Issue: 5
Page: 455-459
Authors: Li Zhang, Huiyi Yang and Jiasen Xu

Role of microRNA in Regulating Cell Signaling Pathways, Cell Cycle, and Apoptosis in Non-Small Cell Lung Cancer

Journal: Current Molecular Medicine
Volume: 16,Issue: 5
Page: 474-486
Authors: D.K. Singh, S. Bose and S. Kumar

Histotype in Non-Small Cell Lung Cancer Therapy and Staging: The Emerging Role of an Old and Underrated Factor

Journal: Current Respiratory Medicine Reviews
Volume: 3,Issue: 1
Page: 69-77
Authors: Giulio Rossi, Alessandro Marchioni, Giuliana Sartori, Lucia Longo, Silvia Piccinini and Alberto Cavazza

Recent Clinical Trials in Non-Small Cell Lung Cancer

Journal: Current Cancer Therapy Reviews
Volume: 2,Issue: 1
Page: 81-99
Authors: Suresh Ramalingam and Chandra P. Belani

Bevacizumab in Non Small Cell Lung Cancer: Development, Current Status and Issues

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 7
Page: 961-971
Authors: C. Sandomenico, R. Costanzo, G. Carillio, M. C. Piccirillo, A. Montanino, M. Di Maio, G. Rocco, N. Normanno, F. Perrone and A. Morabito

Angiogenesis Inhibitors and Vascular Disrupting Agents in Non-Small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 3
Page: 3919-3930
Authors: A. Rossi, P. Maione, M. L. Ferrara, P. C. Sacco, C. Schettino, M. A. Bareschino and C. Gridelli

The Role of the Antiangiogenetic Ramucirumab in the Treatment of Advanced Non Small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 1
Page: 3-13
Authors: Paolo Maione, Assunta Sgambato, Francesca Casaluce, Paola Claudia Sacco, Giuseppe Santabarbara, Antonio Rossi and Cesare Gridelli

Pharmacogenetics of Non-small Cell Lung Cancer (NSCLC): Time to Work it Out?

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 2
Page: 3863-3874
Authors: Elena Galvani, Francesca Toffalorio, Godefridus J. Peters, Tommaso De Pas and Elisa Giovannetti

Challenges and Strategies in Precision Medicine for Non-Small-Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 2
Page: 4374-4385
Authors: Joseph J. Sacco, Hussein Al-Akhrass and Cornelia M. Wilson

Recent Developments of Targeted Therapies in the Treatment of Non-Small Cell Lung Cancer

Journal: Current Drug Discovery Technologies
Volume: 6,Issue: 2
Page: 91-102
Authors: Antonio Rossi, Paolo Maione, Giuseppe Colantuoni, Carmine Ferrara, Emanuela Rossi, Ciro Guerriero, Dario Nicolella, Marzia Falanga, Giovanni Palazzolo and Cesare Gridelli

Interaction of Treatment and Biomarker in Advanced Non-small Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 12,Issue: 1
Page: 51-58
Authors: Pingfu Fu, Nathan A. Pennell, Neelesh Sharma, Qizhi Yi and Afshin Dowlati

Emerging Role of Stereotactic Radiotherapy (SRT) in the Treatment of Early Stage Non-Small Cell Lung Cancer

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 4
Page: 281-287
Authors: Joshua D. Lawson, Ajay Sandhu, Steve Jiang and Arno J. Mundt

Current Status and Future Directions of Multimodality Therapy for Non- Small Cell Lung Cancer of the Superior Sulcus

Journal: Current Cancer Therapy Reviews
Volume: 7,Issue: 1
Page: 2-9
Authors: Rachel E. Sanborn and Charles R. Thomas

Autotaxin and Lysophosphatidic Acid Receptors as Novel Targets for the Radiosensitization of Tumor Vasculature in Non-Small Cell Lung Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 1,Issue: 1
Page: 72-80
Authors: Amanda G. Linkous, Dennis E. Hallahan and Eugenia M. Yazlovitskaya

Small Molecule Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Non Small Cell Lung Cancer Treatment

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 4
Page: 226-235
Authors: Clorinda Schettino, Maria Anna Bareschino, Paolo Maione, Antonio Rossi, Fortunato Ciardiello and Cesare Gridelli

Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 9
Page: 1142-1154
Authors: Federica Biello, Giovanni Burrafato, Erika Rijavec, Carlo Genova, Giulia Barletta, Anna Truini, Simona Coco, Maria Giovanna Dal Bello, Angela Alama, Francesco Boccardo and Francesco Grossi

Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 6
Page: 590-613
Authors: Jingru Liu and Shutao Ma

The Role of Pemetrexed in Advanced Non Small-Cell Lung Cancer: Special Focus on Pharmacology and Mechanism of Action

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 37-47
Authors: M. Joerger, A. Omlin, T. Cerny and M. Fruh

Epidermal Growth Factor Receptor Targeting in Non-Small Cell Lung Cancer: Revisiting Different Strategies Against the Same Target

Journal: Current Drug Targets
Volume: 15,Issue: 1
Page: 1273-1283
Authors: Eduardo Castanon, Patricia Martin, Christian Rolfo, Juan P. Fusco, Lucia Ceniceros, Jairo Legaspi, Marta Santisteban and Ignacio Gil-Bazo

Does Immunohistochemistry Represent a Robust Alternative Technique in Determining Drugable Predictive Gene Alterations in Non-Small Cell Lung Cancer?

Journal: Current Drug Targets
Volume: 18,Issue: 1
Page: 13-26
Authors: Giulio Rossi, Moira Ragazzi, Ione Tamagnini, Maria C. Mengoli, Giada Vincenzi, Fausto Barbieri, Silvia Piccioli, Alessandra Bisagni, Tiziana Vavala, Luisella Righi, Silvia Novello, Francesco Gelsomino and Marcello Tiseo

Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 3
Page: 236-249
Authors: Mangeng Cheng and Gregory R. Ott

Role of EGFR Inhibitors in the Treatment of Central Nervous System Metastases from Non-Small Cell Lung Cancer

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 3
Page: 237-246
Authors: G. L. Ceresoli

Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: A Hard Days Night

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 2
Page: 3958-3972
Authors: Sara Pilotto, Maria Bonomi, Francesco Massari, Michele Milella, Ludovica Ciuffreda, Matteo Brunelli, Matteo Fassan, Marco Chilosi, Aldo Scarpa, Giampaolo Tortora and Emilio Bria

Insights into Angiogenesis in Non-Small Cell Lung Cancer: Molecular Mechanisms, Polymorphic Genes, and Targeted Therapies

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 7,Issue: 1
Page: 118-131
Authors: Ramon Andrade de Mello, Bruno M. Costa, Rui M. Reis and Venceslau Hespanhol

Second Line Treatments in Advanced Platinum-Resistant Non Small Cell Lung Cancer. A Critical Review of Literature

Journal: Reviews on Recent Clinical Trials
Volume: 4,Issue: 1
Page: 27-33
Authors: Davide Tassinari, Federica Carloni, Carlotta Santelmo, Emiliano Tamburini, Luigi Lazzari Agli, Paola Tombesi and Sergio Sartori

The Role of Cetuximab and Other Epidermal Growth Factor Receptor Monoclonal Antibodies in the Treatment of Advanced Non-Small Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 3,Issue: 3
Page: 217-227
Authors: Antonio Rossi, Emilio Bria, Paolo Maione, Giovanni Palazzolo, Marzia Falanga and Cesare Gridelli

Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: A Review of Recent Clinical Trials

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 2
Page: 117-120
Authors: Carrie B. Lee and Mark A. Socinski

Doxorubicin Sensitizes the Non-Small Cell Lung Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated (TRAIL) Apoptosis In Vitro but not In Vivo

Journal: Letters in Drug Design & Discovery
Volume: 8,Issue: 9
Page: 861-867
Authors: Li Fan, Liangran Guo, Jinfeng Ren, Yulong Ren, Zhiqing Pang and Xinguo Jiang

Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management

Journal: Current Drug Safety
Volume: 11,Issue: 1
Page: 62-68
Authors: Assunta Sgambato, Francesca Casaluce, Paola C. Sacco, Giovanni Palazzolo, Paolo Maione, Antonio Rossi, Fortunato Ciardiello and Cesare Gridelli

The Emerging Role of Histology in the Choice of First-Line Treatment of Advanced Non-Small Cell Lung Cancer: Implication in the Clinical Decision-Making

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 1
Page: 1030-1038
Authors: A. Rossi, P. Maione, M. A. Bareschino, C. Schettino, P. C. Sacco, M. L. Ferrara, V. Castaldo and C. Gridelli

Predictive Biomarkers to Tyrosine Kinase Inhibitors for the Epidermal Growth Factor Receptor in Non-Small-Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 7
Page: 851-864
Authors: A. De Luca and N. Normanno

Integrated Therapeutic Approaches in the Treatment of Locally Advanced Non-small Cell Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 6
Page: 844-851
Authors: Massimo Di Maio, Raffaele Costanzo, Pasqualina Giordano, Maria Carmela Piccirillo, Claudia Sandomenico, Agnese Montanino, Guido Carillio, Paolo Muto, David R. Jones, Gennaro Daniele, Francesco Perrone, Gaetano Rocco and Alessandro Morabito

Positron Emission Tomography (PET) in the Evaluation of Response to Therapy in Non-Small Cell Lung Cancer

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 1
Page: 20-27
Authors: Roberto C. Delgado-Bolton and Jose Luis Carreras Delgado

Bonafide Targets of Deregulated microRNAs in Non-Small Cell Lung Cancer as Tool to Identify Novel Therapeutic Targets: A Review

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 1
Page: 55-72
Authors: Monica Cipollini, Stefano Landi and Federica Gemignani

Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 5
Page: 475-485
Authors: Christian Rolfo, Daniele Fanale, David S. Hong, Apostolia M. Tsimberidou, Sarina A. Piha-Paul, Patrick Pauwels, Jan P. Van Meerbeeck, Stefano Caruso, Viviana Bazan, Giuseppe Cicero, Antonio Russo and Elisa Giovannetti

Vascular Endothelial Growth Factor Receptor as Target for Advanced Non-Small Cell Lung Cancer Therapy

Journal: Current Drug Targets
Volume: 11,Issue: 7
Page: 865-874
Authors: Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Rita Ambrosio, Marzia Falanga and Cesare Gridelli

Epidermal Growth Factor Receptor (EGFR) Targeted Therapies in Non- Small Cell Lung Cancer (NSCLC)

Journal: Reviews on Recent Clinical Trials
Volume: 1,Issue: 1
Page: 1-13
Authors: Giulio Metro, Giovanna Finocchiaro, Luca Toschi, Stefania Bartolini, Elisabetta Magrini, Alessandra Cancellieri, Rocco Trisolini, Luciano Castaldini, Giovanni Tallini, Lucio Crino and Federico Cappuzzo

The Potential Role of Pharmacogenomic and Genomic in the Adjuvant Treatment of Early Stage Non Small Cell Lung Cancer

Journal: Current Genomics
Volume: 9,Issue: 4
Page: 252-262
Authors: Clorinda Schettino, Maria A. Bareschino, Paolo Maione, Antonio Rossi, Fortunato Ciardiello and Cesare Gridelli

FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 5
Page: 342-348
Authors: D. L. Cortinovis, F. Andriani, A. Livio, A. Fabbri, F. Perrone, B. Marcomini, S. Pilotti, L. Mariani, P. Bidoli, E. Bajetta, L. Roz and G. Sozzi

The Role of Chemotherapy and Radiation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 67-73
Authors: Timothy D. Wagner and Gary Y. Yang

Efficacy and Safety of Antigen-specific Immunotherapy in the Treatment of Patients with Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis

Journal: Current Cancer Drug Targets
Volume: 18,Issue: 0
Page: 1-11
Authors: Bing-Di Yan, Xiao-Feng Cong, Sha-Sha Zhao, Meng Ren, Zi-Ling Liu, Zhi Li, Chen Chen and Lei Yang*

Significant Changes in D2-like Dopamine Gene Receptors Expression Associated with Non- Small -Cell Lung Cancer: Could it be of Potential Use in the Design of Future Therapeutic Strategies?

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 4
Page: 304-310
Authors: Mojhgan Shaikhpoor, Ghasem Ahangari, Majid Sadeghizadeh, Adnan Khosravi and Gholamreza Derakhshani Deilami

Pharmacogenomics of Non-Small Cell Lung Cancer

Journal: Current Pharmacogenomics
Volume: 5,Issue: 3
Page: 228-234
Authors: James Spicer, Andrew Futreal and Johann De Bono

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 5
Page: 818-832
Authors: Elena Galvani, Roberta Alfieri, Elisa Giovannetti, Andrea Cavazzoni, Silvia La Monica, Maricla Galetti, Claudia Fumarola, Mara Bonelli, Marco Mor, Marcello Tiseo, Godefridus J. Peters, Pier Giorgio Petronini and Andrea Ardizzoni

Increased Expression of IRE1? Associates with the Resistant Mechanism of Osimertinib (AZD9291)-resistant non-small Cell Lung Cancer HCC827/OSIR Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 0
Page: 1-6
Authors: Zheng-hai Tang*, Min-Xia Su, Xia Guo, Xiao-Ming Jiang, Lin Jia, Xiuping Chen and Jin-Jian Lu

Mechanisms of Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-Small-Cell Lung Cancer: Clinical and Molecular Considerations

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 1
Page: 1613-1628
Authors: A. Pallis, E. Briasoulis, H. Linardou, C. Papadimitriou, D. Bafaloukos, P. Kosmidis and S. Murray

Selumetinib in Advanced Non Small Cell Lung Cancer (NSCLC) Harbouring KRAS Mutation: Endless Clinical Challenge to KRAS-mutant NSCLC.

Journal: Reviews on Recent Clinical Trials
Volume: 8,Issue: 2
Page: 93-100
Authors: Paolo Maione, Assunta Sgambato, Antonio Rossi, Paola Claudia Sacco, Maria Anna Bareschino, Clorinda Schettino, Francesca Casaluce, Fortunato Ciardiello and Cesare Gridelli

Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 17,Issue: 6
Page: 739-745
Authors: David M. Straughan, Sa d C. Azoury and Vivek Shukla

Targeted Therapies for Advanced Non-Small Cell Lung Cancer

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 15,Issue: 8
Page: 641-655
Authors: Ioannis Starakis, Achilleas Nikolakopoulos and Elias E. Mazokopakis

An Overview: Current Systemic Therapies for Advanced Non-Small Cell Lung Cancer

Journal: Current Respiratory Medicine Reviews
Volume: 7,Issue: 5
Page: 354-363
Authors: Michael Ong and Mark D. Vincent

Pemetrexed: Potential Role in the Adjuvant Chemotherapy of Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 78-84
Authors: Mark Vincent

Across the Universe of K-Ras Mutations in Non-Small-Cell-Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 2
Page: 3933-3943
Authors: Sheila Piva, Monica Ganzinelli, Marina Chiara Garassino, Elisa Caiola, Gabriella Farina, Massimo Broggini and Mirko Marabese

Clinical Pharmacology of EGFR/Met Inhibitors in Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 15,Issue: 1
Page: 1263-1272
Authors: Shigehiro Yagishita and Akinobu Hamada

Epigenetic Regulation of EMT in Non-Small Cell Lung Cancer

Journal: Current Cancer Drug Targets
Volume: 18,Issue: 1
Page: 89-96
Authors: Karen O’Leary, Alice Shia and Peter Schmid*

PARP Inhibitors: An Interesting Pathway also for Non-Small Cell Lung Cancer?

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 2
Page: 3875-3882
Authors: Matteo Giaj Levra, Ken Andre Olaussen, Silvia Novello and Jean-Charles Soria

Docetaxel (Taxotere) in the Treatment of Non-Small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 8
Page: 869-877
Authors: Vassilis Georgoulias

Immunotherapy for Non-Small Cell Lung Cancer - Finally a Hint of Hope

Journal: Reviews on Recent Clinical Trials
Volume: 11,Issue: 2
Page: 87-92
Authors: Gonzalo Recondo, Gonzalo Recondo, Fernando Galanternik, Martín Greco, Máximo de la Vega, E. Diaz Cantón and Matías E. Valsecchi

Recent Patents for Predictive and Prognostic Biomarkers in Non-Small-Cell Lung Cancer

Journal: Recent Patents on Biomarkers
Volume: 1,Issue: 2
Page: 119-138
Authors: Vassiliki Saloura and Petros D. Grivas

Esophagitis, Treatment-Related Toxicity in Non-Small Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 7,Issue: 1
Page: 31-35
Authors: Voichita Bar-Ad, Nitin Ohri and Maria Werner-Wasik

Segmentation and Classification of Lung Cancer: A Review

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 82-99
Authors: Javeria Amin, Muhammad Sharif and Mussarat Yasmin

Do we Need Maintenance Chemotherapy in Advanced NSCLC in the Era of Immune and Targeted Therapy?

Journal: Current Cancer Therapy Reviews
Volume: 14,Issue: 0
Page: 1-8
Authors: Ahmed A. Nagy*, Omar Abdelrahman, Heba Abdullah and Ahmed Negida

Clinical Approaches to Immunotherapy in Non-Small Cell Lung Cancer: Current and Future Perspectives

Journal: Current Molecular Pharmacology
Volume: 9,Issue: 3
Page: 183-195
Authors: Shawn J. Rice, Bruce Miller, Matthias Wagman, Daniel S. Jamorabo, Xin Liu and Chandra P. Belani

Application of PET to the Diagnosis, Staging, and Treatment of Locally Advanced Non-small Cell Lung Cancer

Journal: Current Medical Imaging Reviews
Volume: 11,Issue: 2
Page: 91-98
Authors: Fei Li and Mark Landis

Pharmacological Approaches in an Experimental Model of Non-Small Cell Lung Cancer: Effects on Tumor Biology

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 3
Page: 5300-5310
Authors: Mercè Mateu-Jimenez, Clara Fermoselle, Federico Rojo, Javier Mateu, Raúl Peña, Alejandro J. Urtreger, Miriam J. Diament, Elisa D. Bal de Kier Joffé, Lara Pijuan, Antonio García de Herreros and Esther Barreiro

Targeted Therapies in Non-Small Cell Lung Cancer: Proven Concepts and Unfulfilled Promises.

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 4
Page: 271-294
Authors: Jutta Auberger, Judith Loeffler-Ragg, Walter Wurzer and Wolfgang Hilbe

Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 12-28
Authors: Elisa Giovannetti, Richard Honeywell, Axel R. Hanauske, Christina Tekle, Bart Kuenen, Jennifer Sigmond, Giuseppe Giaccone and Godefridus J. Peters

Next Generation Sequencing in Non-Small Cell Lung Cancer: New Avenues Toward the Personalized Medicine

Journal: Current Drug Targets
Volume: 16,Issue: 1
Page: 47-59
Authors: Simona Coco, Anna Truini, Irene Vanni, Maria Giovanna Dal Bello, Angela Alama, Erika Rijavec, Carlo Genova, Giulia Barletta, Claudio Sini, Giovanni Burrafato, Federica Biello, Francesco Boccardo and Francesco Grossi

The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?

Journal: Current Drug Targets
Volume: 15,Issue: 1
Page: 1284-1292
Authors: Francesco Passiglia, Nele Van Der Steen, Luis Raez, Patrick Pauwels, Ignacio Gil-Bazo, Edgardo Santos, Daniele Santini, Giovanni Tesoriere, Antonio Russo, Giuseppe Bronte, Karen Zwaenepoel, Federico Cappuzzo and Christian Rolfo

New Antiangiogenetic Therapy Beyond Bevacizumab in the Treatment of Advanced Non Small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 3
Page: 4763-4772
Authors: Paola Claudia Sacco, Paolo Maione, Antonio Rossi, Assunta Sgambato, Francesca Casaluce, Giovanni Palazzolo and Cesare Gridelli

Comparative Proteomics and Bioinformatics Analysis of Tissue from Non-Small Cell Lung Cancer Patients

Journal: Current Proteomics
Volume: 14,Issue: 1
Page: 58-77
Authors: Sevgi Gezici, Mehmet Ozaslan, Gurler Akpinar, Murat Kasap, Maruf Sanli and Levent Elbeyli

Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 11,Issue: 4
Page: 297-305
Authors: Anshu Giri, Simrit S. Walia and Ajeet Gajra

The Natural Tumor Suppressor Protein Maspin and Potential Application in Non Small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 1
Page: 1877-1881
Authors: Fulvio Lonardo, Xiaohua Li, Alexander Kaplun, Ayman Soubani, Seema Sethi, Shirish Gadgeel and Shijie Sheng

Immune Checkpoint Inhibitors for Non-small-cell Lung Cancer: Does that Represent a ‘New Frontier’?

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 3
Page: 307-313
Authors: Sara Pilotto, Stefania Kinspergher, Umberto Peretti, Anna Calio, Luisa Carbognin, Roberto Ferrara, Matteo Brunelli, Marco Chilosi, Giampaolo Tortora and Emilio Bria

Metabolic Response Assessment in Non-Small Cell Lung Cancer Patients after Platinum-Based Therapy: A Preliminary Analysis

Journal: Current Medical Imaging Reviews
Volume: 11,Issue: 4
Page: 218-227
Authors: Alessandro Stefano, Nunziatina Porcino, Giuseppe Banna, Giorgio Russo, Vanessa Mocciaro, Giuseppe Anile, Stefania Gieri, Sebastiano Cosentino, Gabriella Mure, Sara Baldari, Maria Gabriella Sabini, Danile Sardina, Filippo Fraggetta, Salvatore Vitabile, Maria Carla Gilardi and Massimo Ippolito

Non-Small Cell Lung Cancer: From Cytotoxic Systemic Chemotherapy to Molecularly Targeted Therapy

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 4,Issue: 3
Page: 231-245
Authors: Alfredo Cesario, Sonya Trombino, Domenico Galetta, Stefano Margaritora, Carmelina Murolo, Lorenzo Dominioni, Andrea Imperatori, Luigi Festi, Pierluigi Granone and Patrizia Russo

Pharmacokinetic Study of Weekly (Days 1-5) Low-dose S-1 in Patients with Non-Small-Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 7,Issue: 2
Page: 167-172
Authors: Tsuyoshi Shoji, Makoto Sonobe, Hiroaki Sakai, Takuji Fujinaga, Toshihiko Sato, Fengshi Chen, Ryo Miyahara, Toru Bando, Hiromi Wada and Hiroshi Date

The Combination of New Immunotherapy and Radiotherapy: A N ew Potential Treatment for Locally Advanced Non-Small Cell Lung Cancer

Journal: Current Clinical Pharmacology
Volume: 12,Issue: 1
Page: 4-10
Authors: Paola C. Sacco, Paolo Maione, Cesare Guida and Cesare Gridelli*

The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 58-60
Authors: Steven Tucker

MicroRNAs in Non-small Cell Lung Cancer: Current Status and Future Therapeutic Promises

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 2
Page: 3982-3990
Authors: D. Cortinovis, V. Monica, F Pietrantonio, G.L. Ceresoli, C.M. La Spina and L. Wannesson

miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke

Journal: MicroRNA
Volume: 7,Issue: 1
Page: 38-53
Authors: Niraj Babu, Jayshree Advani, Hitendra S. Solanki, Krishna Patel, Ankit Jain, Aafaque Ahmad Khan, Aneesha Radhakrishnan, Nandini A. Sahasrabuddhe, Premendu Prakash Mathur, Bipin Nair, Thottethodi Subrahmanya Keshava Prasad, Xiaofei Chang, David Sidransky, Harsha Gowda* and Aditi Chatterjee*

Evaluation of Effect of Triterpenes and Limonoids on Cell Growth, Cell Cycle and Apoptosis in Human Tumor Cell Lines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 1
Page: 769-776
Authors: Cristiane M. Cazal, Kantima Choosang, Vanessa Gisele P. Severino, Marcio S. Soares, Andre Lucio F. Sarria, Joao B. Fernandes, Maria Fatima G.F. Silva, Paulo Cezar Vieira, Pannee Pakkong, Gabriela M. Almeida, M. Helena Vasconcelos, Maria S.J. Nascimento and Madalena M.M. Pinto

Genomic and Cellular Pathology of Lung Cancer

Journal: Current Respiratory Medicine Reviews
Volume: 7,Issue: 5
Page: 313-322
Authors: Sandy D. Der, Roya Navab, Kota Ishizawa and Ming-Sound Tsao

Lung Cancer Vaccines

Journal: Current Gene Therapy
Volume: 7,Issue: 6
Page: 469-484
Authors: Rob Eager, Lindsey Harle and John J. Nemunaitis

Apoptosis and Apoptosis-Based Therapy in Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 9
Page: 952-957
Authors: Cheng-Xiong Xu, Hua Jin and Myung-Haing Cho

The Hypomethylation Agent Bisdemethoxycurcumin Acts on the WIF-1 Promoter, Inhibits the Canonical Wnt Pathway and Induces Apoptosis in Human Non-Small-Cell Lung Cancer

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 9
Page: 1098-1110
Authors: Y.-L. Liu, H.-P. Yang, X.-D. Zhou, L. Gong, C.-L. Tang and H.-J. Wang

Resistance to Crizotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) with ALK Rearrangement: Mechanisms, Treatment Strategies and New Targeted Therapies

Journal: Current Clinical Pharmacology
Volume: 11,Issue: 2
Page: 77-87
Authors: Francesca Casaluce, Assunta Sgambato, Paola Claudia Sacco, Giovanni Palazzolo, Paolo Maione, Antonio Rossi, Fortunato Ciardiello and Cesare Gridelli

The Role of EGFR Tyrosine Kinase Inhibitors in the First-Line Treatment of Advanced Non Small Cell Lung Cancer Patients Harboring EGFR Mutation

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 2
Page: 3337-3352
Authors: A. Sgambato, F. Casaluce, P. Maione, A. Rossi, E. Rossi, A. Napolitano, G. Palazzolo, M. A. Bareschino, C. Schettino, P. C. Sacco, F. Ciadiello and C. Gridelli

Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and New Therapeutic Perspectives in Non Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 12,Issue: 6
Page: 922-933
Authors: Laura Bonanno, Antonio Jirillo and Adolfo Favaretto

Apicidin Inhibited Proliferation and Invasion and Induced Apoptosis via Mitochondrial Pathway in Non-small Cell Lung Cancer GLC-82 Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 1
Page: 1374-1382
Authors: Jianye Zhang, Zhenzhu Lai, Wenjing Huang, Huiping Ling, Minting Lin, Sili Tang, Yun Liu and Yiwen Tao*

Chitosan Nano-encapsulation Enhances Gedunin Cytotoxicity A gainst Human Non-small-cell Lung Cancer (NCI-H292) Cell Line

Journal: Drug Delivery Letters
Volume: 7,Issue: 3
Page: 219-226
Authors: Chukwumaobim D.U. Nwokwu, Chukwumaobim D.U. Nwokwu, Sameera R. Samarakoon, Sameera R. Samarakoon, Desiree N. Karunaratne*, Desiree N. Karunaratne*, Nuwanthi P. Katuvawila, Nuwanthi P. Katuvawila, Meran K. Ediriweera, Meran K. Ediriweera, Kamani H. Tennekoon and Kamani H. Tennekoon

Detection of EGFR Somatic Mutations in Non-Small Cell Lung Cancer (NSCLC) Using a Novel Mutant-Enriched Liquidchip (MEL) Technology

Journal: Current Drug Metabolism
Volume: 13,Issue: 7
Page: 1007-1011
Authors: Li Zhang, Huiyi Yang, Yanwei Zhao, Wenchao Liu, Shiyang Wu, Jiaying He, Xiaodi Luo, Zeyao Zhu, Jiasen Xu, Qinghua Zhou and Lifen Ren-Heidenreich

A Computational Study of Three Frequent Mutations of EGFR and their Effects on Protein Dimer Formation and Non-Small Cell Lung Cancer Drug Resistance

Journal: Current Bioinformatics
Volume: 11,Issue: 3
Page: 382-391
Authors: Zhiyong Shen, Debby D. Wang, Lichun Ma, Hong Yan, Maria P. Wong and Victor H.F. Lee

Molecular Mechanisms and Modulation of Key Pathways Underlying the Synergistic Interaction of Sorafenib with Erlotinib in Non-Small-Cell-Lung Cancer (NSCLC) Cells

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 5
Page: 927-939
Authors: E. Giovannetti, M. Labots, H. Dekker, E. Galvani, J.S.W. Lind, R. Sciarrillo, R. Honeywell, E.F. Smit, H.M. Verheul and G.J. Peters

Growth Inhibition of Human Non-Small Lung Cancer Cells H460 By Green Tea and Ginger Polyphenols

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 4
Page: 383-390
Authors: Mohamed Hessien, Saad El-Gendy, Thoria Donia and Morsy Abou Sikkena

Recent Advances in Small Molecule Inhibitors of VEGFR and EGFR Signaling Pathways

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 1
Page: 1571-1590
Authors: Haizhen Zhong and J. Phillip Bowen

Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 1
Page: 1640-1650
Authors: F. Petrelli, K. Borgonovo, M. Cabiddu, M. Ghilardi and S. Barni

Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 9,Issue: 3
Page: 382-393
Authors: Suresh Kumar and Ritesh Agrawal

Radiation Therapy in the Management of Lung Cancer

Journal: Current Respiratory Medicine Reviews
Volume: 7,Issue: 5
Page: 323-339
Authors: Tarek Hijal, Jonathan Wan and Luis Souhami

Recent Advance in Drug Development of Squamous Cell Carcinoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 7
Page: 816-827
Authors: Jun Lei, Bing Fu, Hang Yin, Guanxiu Tang, Shujuan Zhu, Chunli Yan and Quanyong He

Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 0
Page: 1-14
Authors: Xiaohong Du, Jitai Zhang, Juping Wang*, Xiaoming Lin* and Feng Ding*

Therapeutic Approaches for the Treatment of Epidermal Growth Factor Receptor Mutated Lung Cancer

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 0
Page: 1-19
Authors: Dhaval Sanchala, Lokesh K Bhatt* and Kedar S Prabhavalkar

Design, Synthesis and Biological Evaluation of Quinoxalin-2(1H)-one Derivatives as EGFR Tyrosine Kinase Inhibitors

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 2
Page: 267-273
Authors: Xuemei Qin, Xiao Han, Liming Hu, Zhipeng Li, Zhufeng Geng, Zhanyang Wang, Chengchu Zeng and Xiangqian Xiao

Current Molecularly Targeting Therapies in NSCLC and Melanoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 7
Page: 856-868
Authors: Supriya Rajanna, Ichwaku Rastogi, Luke Wojdyla, Hiroko Furo, Agnes Kulesza, Leo Lin, Bonnie Sheu, Mark rakes, Marko Ivanovich and Neelu Puri

Recent Progress in Therapeutic and Diagnostic Applications of Lanthanides

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11,Issue: 8
Page: 678-694
Authors: J. Zhang, Y. Li, X. Hao, Q. Zhang, K. Yang, L. Li, L. Ma, S. Wang and X. Li

Pivotal Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in Inflammatory Pulmonary Diseases

Journal: Current Protein & Peptide Science
Volume: 17,Issue: 4
Page: 332-342
Authors: Feng Qian, Jing Deng, Gang Wang, Richard D. Ye and John W. Christman

Metallothioneins and Cancer

Journal: Current Protein & Peptide Science
Volume: 10,Issue: 4
Page: 360-375
Authors: Tomas Eckschlager, Vojtech Adam, Jan Hrabeta, Katarina Figova and Rene Kizek

Design, Synthesis and Molecular Modeling Studies of Some Heterocyclic Compounds Derived from the Suzuki-coupling of 6-bromo-1,3,4-oxadiazine Together with their Antitumor and Anti-leishmanial Evaluations

Journal: Current Organic Chemistry
Volume: 17,Issue: 1
Page: 1910-1918
Authors: Rafat M. Mohareb, Sherif M. Sherif and Adel Abou Elkair

Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity

Journal: Medicinal Chemistry
Volume: 14,Issue: 4
Page: 333-343
Authors: Maya Z. Gibson, Minh A. Nguyen and Sarah K. Zingales*

Targeting CREB for Cancer Therapy: Friend or Foe

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 4
Page: 384-391
Authors: X. Xiao, B.X. Li, B. Mitton, A. Ikeda and K.M. Sakamoto

Radiation-Induced Lung Injury Following Therapy for Thoracic Malignancy

Journal: Current Respiratory Medicine Reviews
Volume: 1,Issue: 3
Page: 317-323
Authors: Ross K. Morgan, Lisa A. Kachnic and Ross Summer

High Throughput Screening for Protein Kinase Inhibitors

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 8,Issue: 2
Page: 181-195
Authors: Holger Wesche, Shou-Hua Xiao and Steve W. Young

Recent Developments of Small Molecule EGFR Inhibitors Based on the Quinazoline Core Scaffolds

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 4
Page: 391-406
Authors: Yu-Jing Liu, Cheng-Mei Zhang and Zhao-Peng Liu

Neuropeptides as Autocrine Growth Factors in Cancer Cells

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 6
Page: 495-509
Authors: Terry W. Moody, Daniel Chan, Jan Fahrenkrug and Robert T. Jensen

Efficacy and Tolerability of Vinorelbine in the Cancer Therapy

Journal: Current Drug Safety
Volume: 6,Issue: 3
Page: 185-193
Authors: Giuseppina Galano, Mariella Caputo, Mario Felice Tecce and Anna Capasso

Cardiotonic Steroids-Mediated Targeting of the Na+/K+-ATPase to Combat Chemoresistant Cancers

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 5
Page: 627-646
Authors: T. Mijatovic, F. Dufrasne and R. Kiss

Gold Salts Therapy in Respiratory Diseases

Journal: Current Respiratory Medicine Reviews
Volume: 9,Issue: 5
Page: 328-333
Authors: Ori-Michael J. Benhamou, Maly N. Oron, Maor Waldman and Or Kalchiem-Dekel

ROS1 Kinase Inhibitors for Molecular-Targeted Therapies

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 2
Page: 142-160
Authors: M.M. Al-Sanea, A.Z. Abdelazem, B.S. Park, K.H. Yoo, T. Sim, Y.J. Kwon and S.H. Lee

ATP Citrate Lyase (ACLY): A Promising Target for Cancer Prevention and Treatment

Journal: Current Drug Targets
Volume: 16,Issue: 2
Page: 156-163
Authors: Amrita Devi Khwairakpam, Mayengbam Singh Shyamananda, Bethsebie Lalduhsaki Sailo, Sivakumar Raju Rathnakaram, Ganesan Padmavathi, Jibon Kotoky and Ajaikumar B. Kunnumakkara

Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy

Journal: Current Drug Targets
Volume: 16,Issue: 1
Page: 1448-1463
Authors: Ana Vanessa Nascimento, Hassan Bousbaa, Domingos Ferreira and Bruno Sarmento

Application of Monoclonal Antibodies as Cancer Therapy in Solid Tumors

Journal: Current Clinical Pharmacology
Volume: 7,Issue: 2
Page: 137-145
Authors: Rodrigo Dienstmann, Ben Markman and Josep Tabernero

Receptor Tryosine Kinase Inhibitors as Potent Weapons in War Against Cancers

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 7
Page: 758-776
Authors: P. Sapra Sharma, R. Sharma and T. Tyagi

3D-QSAR and Docking Studies on 2-acyliminobenzimidazoles Derivatives as Potent ALK Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 12,Issue: 3
Page: 219-233
Authors: Qianqian Lva, Zhi Wang, Zhonghua Wanga*, Fanhong Wu* and Liping Cheng

Methodological Issues of Clinical Research with EGFR Inhibitors

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 4
Page: 292-302
Authors: Alessandro Morabito, Maria Carmela Piccirillo, Katia Monaco, Fabiano Falasconi, Nicola Normanno and Francesco Perrone

Applications of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Pulmonary Disease

Journal: Current Respiratory Medicine Reviews
Volume: 6,Issue: 2
Page: 133-141
Authors: Andrew R.L. Medford

Is ?7-nAChR a Possible Target for Lung Cancer and Malignant Pleural Mesothelioma Treatment?

Journal: Current Drug Targets
Volume: 13,Issue: 5
Page: 688-694
Authors: Alfredo Cesario, Patrizia Russo, Candida Nastrucci and Pierluigi Granone

Second Generation Taxanes: from the Natural Framework to the Challenge of Drug Resistance

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3,Issue: 2
Page: 133-138
Authors: Cristiano Ferlini, Iwao Ojima, Mariagrazia Distefano, Daniela Gallo, Antonella Riva, Paolo Morazzoni, Ezio Bombardelli, Salvatore Mancuso and Giovanni Scambia

Synthesis of Xanthones and Benzophenones as Inhibitors of Tumor Cell Growth

Journal: Letters in Drug Design & Discovery
Volume: 7,Issue: 7
Page: 487-493
Authors: Elisangela Costa, Emilia Sousa, Nair Nazareth, Maria S.J. Nascimento and Madalena M.M. Pinto

Targeted Therapies in Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 2
Page: 188-206
Authors: Robert Pirker and Martin Filipits

The Potential and Rationale for COX-2 Inhibitors in Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 6,Issue: 3
Page: 209-220
Authors: Kostyantyn Krysan, Karen L. Reckamp, Sherven Sharma and Steven M. Dubinett

Lung Cancer Stem Cells as a Target for Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 2
Page: 164-171
Authors: Elieser Gorelik, Anna Lokshin and Vera Levina

Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 5
Page: 673-687
Authors: Jian-Feng Tang, Qing Wen, Jian Sun, Wei-Ming Zhang and Hai-Liang Zhu

Role of Colloidal Drug Delivery Carriers in Taxane-mediated Chemotherapy: A Review

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 3
Page: 5127-5143
Authors: Pramod Kumar, Kaisar Raza, Lokesh Kaushik, Ruchi Malik, Shweta Arora and Om Prakash Katare

ErbB Antagonists Patenting: “Playing Chess with Cancer”

Journal: Recent Patents on Biotechnology
Volume: 2,Issue: 3
Page: 181-187
Authors: Sami Aifa and Ahmed Rebai

Etoposide: Discovery and Medicinal Chemistry

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 1
Page: 2443-2466
Authors: Philippe Meresse, Elsa Dechaux, Claude Monneret and Emmanuel Bertounesque

Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 1
Page: 2811-2829
Authors: Maha Elnaggar, Elisa Giovannetti and Godefridus J. Peters

Predictive Markers for Haematological Toxicity of Pemetrexed

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 48-57
Authors: S. C.H. Kao, V. H. Phan and S. J. Clarke

Optimizing Anti-EGFR Strategies in Cancer Treatment

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 4
Page: 267-275
Authors: Luca Toschi, Giovanna Finocchiaro, Isabella Garassino, Fabio De Vincenzo, Elisabetta Campagnoli, Giovanni Luca Ceresoli, Raffaele Cavina, Paolo Andrea Zucali, Armando Santoro and Federico Cappuzzo

Pharmacokinetics of Gefitinib: Roles of Drug Metabolizing Enzymes and Transporters

Journal: Current Drug Delivery
Volume: 14,Issue: 2
Page: 282-288
Authors: Can Zhao, Shu-Yan Han and Ping-Ping Li

Clinico-Pathologic and Biologic Predictors of EGFR Inhibitors Activity and Efficacy in Lung and in Colorectal Cancer

Journal: Current Signal Transduction Therapy
Volume: 3,Issue: 3
Page: 234-243
Authors: Maria Anna Bareschino, Clorinda Schettino, Linda Alvino, Cesare Gridelli and Fortunato Ciardiello

Tumor Markers in Patients with Benign and Malignant Pulmonary Diseases; Competitive Evaluation of ProGRP, NSE and Cyfra 21-1

Journal: Recent Patents on Biomarkers
Volume: 3,Issue: 2
Page: 145-152
Authors: Bijan B. Dilmaghani-Marand and Gerhard M. Oremek

Long Noncoding RNA MALAT1: Insights into its Biogenesis and Implications in Human Disease

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 3
Page: 5017-5028
Authors: Yuting Wu, Cheng Huang, Xiaoming Meng and Jun Li

In Vitro Synergistic Interaction between DTA0100 and Radiation in Human Cancer Cell Lines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 8
Page: 988-993
Authors: Elisa Bordon, Leticia G. Leon, Carla Rios-Luci, Pedro C. Lara and Jose M. Padron

Fibrates in the Chemical Action of Daunorubicin

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 3
Page: 366-369
Authors: Ganesaratnam K. Balendiran

Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology

Journal: Current Drug Targets
Volume: 10,Issue: 1
Page: 923-936
Authors: Antonio Gualberto and Michael Pollak

Role of Tyrosine Kinase Inhibitor Molecules in Non Small Cell Lung Cancer:From Benchside to Bedside

Journal: Current Respiratory Medicine Reviews
Volume: 3,Issue: 2
Page: 159-167
Authors: Alessia Catassi, Alfredo Cesario, Pierluigi Granone and Patrizia Russo

Overview of Ribonucleotide Reductase Inhibitors: An Appealing Target in Anti-Tumour Therapy

Journal: Current Medicinal Chemistry
Volume: 12,Issue: 1
Page: 1283-1294
Authors: Nuno M.F.S.A. Cerqueira, Susana Pereira, Pedro A. Fernandes and Maria J. Ramos

Review on EGFR Inhibitors: Critical Updates

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16,Issue: 1
Page: 1134-1166
Authors: Davinder Singh, Bhupinder Kumar Attri, Rupinder Kaur Gill and Jitender Bariwal

Inhalable Nanostructures for Lung Cancer Treatment: Progress and Challenges

Journal: Current Nanomedicine
Volume: 8,Issue: 0
Page: 1-26
Authors: Akashdeep Singh, Sachin Bhatia and Vikas Rana*


Predictive Molecular Markers of Response to Epidermal Growth Factor Receptor(EGFR) Family-Targeted Therapies

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 8
Page: 799-812
Authors: Sarah Barton, Naureen Starling and Charles Swanton

Genetics of Preneoplasia: Lessons from Lung Cancer

Journal: Current Molecular Medicine
Volume: 7,Issue: 1
Page: 3-14
Authors: Ignacio I. Wistuba

Design of New Oxazaphosphorine Anticancer Drugs

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 9
Page: 963-978
Authors: Jun Liang, Min Huang, Wei Duan, Xue-Qing Yu and Shufeng Zhou

Epidermal Growth Factor Receptor Inhibitors: A New Prospective in the Treatment of Lung Cancer

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 4,Issue: 2
Page: 139-148
Authors: M. Tiseo, M. Loprevite and A. Ardizzoni

Combining Anti-Epidermal Growth Factor Receptor (EGFR) and Anti-Angiogenic Strategies in Advanced NSCLC: We Should have Known Better...

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 2
Page: 3901-3913
Authors: Massimo Di Maio, Alessandro Morabito, Maria Carmela Piccirillo, Gennaro Daniele, Pasqualina Giordano, Raffaele Costanzo, Claudia Sandomenico, Agnese Montanino, Gaetano Rocco and Francesco Perrone

The History, Mechanism and Clinical Use of Oral 5-Fluorouracil Derivative Chemotherapeutic Agents

Journal: Current Pharmaceutical Biotechnology
Volume: 1,Issue: 2
Page: 137-164
Authors: Fumihiro Tanaka, Tatsuo Fukuse, Hiromi Wada and Masakazu Fukushima

Current Strategies to Overcome Resistance to ALK-Inhibitor Agents

Journal: Current Drug Metabolism
Volume: 16,Issue: 7
Page: 585-596
Authors: Francesca Simionato, Melissa Frizziero, Carmine Carbone, Giampaolo Tortora and Davide Melisi

Factors Driving the Choice of the Best Second-Line Treatment of Advanced NSCLC

Journal: Reviews on Recent Clinical Trials
Volume: 6,Issue: 1
Page: 44-51
Authors: Paolo Maione, Antonio Rossi, Maria Anna Bareschino, Paola Claudia Sacco, Clorinda Schettino, Marzia Falanga, Valentina Barbato, Rita Ambrosio and Cesare Gridelli

Insight into Discovery of Next Generation Reversible TMLR Inhibitors Targeting EGFR Activating and Drug Resistant T790M Mutants

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 7
Page: 617-636
Authors: Subhash Mohan Agarwal*, Divyani Pal, Mansi Gupta and Ravi Saini

Feature Classification and Analysis of Lung Cancer Related Genes through Gene Ontology and KEGG Pathways

Journal: Current Bioinformatics
Volume: 11,Issue: 1
Page: 40-50
Authors: You Zhou, Biqing Li, Yuchao Zhang, Lei Chen and Xiangyin Kong

Back to the Bench? MEK and ERK Inhibitors for the Treatment of KRAS Mutant Lung Adenocarcinoma

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 5
Page: 558-574
Authors: Jens Kohler*, Marco Catalano and Chiara Ambrogio*

Current Status and Perspectives Regarding the Therapeutic Potential of Targeting EGFR Pathway by Curcumin in Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 1
Page: 2002-2008
Authors: Mojtaba Shafiee, Elham Mohamadzade, Soudabeh ShahidSales, Samaneh Khakpouri, Mina Maftouh, Seyed Alireza Parizadeh, Seyed Mahdi Hasanian* and Amir Avan*

From Biology to Therapy: Improvements of Therapeutic Options in Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 0
Page: 1-6
Authors: Luigi Formisano, Valerie M. Jansen, Roberta Marciano and Roberto Bianco*

Crizotinib Versus Chemotherapy on ALK-positive NSCLC: A Systematic Review of Efficacy and Safety

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 0
Page: 1-9
Authors: Mingxia Wang, Guanqi Wang, Haiyan Ma and Baoen Shan*

Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 2
Page: 169-176
Authors: Yuanxin Liang, Jinwu Zeng, Linda Jelicks, Shengwei Ma, Jing Liu, Jingsong Mei, Roman Perez-Soler and Yiyu Zou

Biological Evaluation of 99mTc-HYNIC-EDDA/tricine-(Ser)3-D4 Peptide for Tumor Targeting

Journal: Current Radiopharmaceuticals
Volume: 10,Issue: 2
Page: 123-130
Authors: Ziba Kazemi, Mona Haddad Zahmatkesh , Seyed Mohammad Abedi and Seyed Jalal Hosseinimehr *

Ultrasound Assisted-synthesis and Biological Evaluation of Piperazinylprop- 1-en-2-yloxy-2H-chromen-2-ones as Cytotoxic Agents

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 1
Page: 1195-1205
Authors: Anna Pratima G. Nikalje*, Shailee V. Tiwari, Jaydeep G. Tupe, Vivek K. Vyas and Gulamnizami Qureshi

The c-Met Inhibitors: A New Class of Drugs in the Battle Against Advanced Nonsmall- Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 3
Page: 6155-6168
Authors: Assunta Sgambato, Francesca Casaluce, Paolo Maione, Antonio Rossi, Emanuela Rossi, Alba Napolitano, Giovanni Palazzolo, Maria Anna Bareschino, Clorinda Schettino, Paola Claudia Sacco, Fortunato Ciardiello and Cesare Gridelli

Anticancer Activity of New Compounds Using Benzimidazole as a Scaffold

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 7
Page: 1003-1018
Authors: Mohd Rashid, Asif Husain, Mohammad Shaharyar and Mohd Sarafroz

Arsenic Trioxide Exerts Anti-lung Cancer Activity by Inhibiting Angiogenesis

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 6
Page: 557-566
Authors: Meng-Hang Yang, Yuan-Sheng Zang, Hai Huang, Kun Chen, Bing Li, Guang-Yuan Sun and Xue-Wei Zhao

The Impact of Folate Status on the Efficacy of Colorectal Cancer Treatment

Journal: Current Drug Metabolism
Volume: 12,Issue: 1
Page: 975-984
Authors: Letizia Porcelli, Yehuda G. Assaraf, Amalia Azzariti, Angelo Paradiso, Gerrit Jansen and Godefridus J. Peters

Effective Treatment of Human Lung Cancer by Targeting Tissue Factor with a Factor VII-Targeted Photodynamic Therapy

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 9
Page: 1069-1081
Authors: J. Cheng, J. Xu, J. Duanmu, H. Zhou, C. J. Booth and Z. Hu


Risk Factors for Lung Cancer in Never Smokers: A Recent Review Including Genetics

Journal: Current Respiratory Medicine Reviews
Volume: 12,Issue: 1
Page: 74-117
Authors: Anne Marie Quinn, William G. Newman and Philip S. Hasleton

An Interventional Pulmonologist’s Tool: Endobronchial Ultrasound- Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Thoracic Disease — An Update

Journal: Current Respiratory Medicine Reviews
Volume: 8,Issue: 5
Page: 396-408
Authors: Andrew R.L. Medford

Bioactive Secondary Metabolites from a Thai Collection of Soil and Marine-Derived Fungi of the Genera Neosartorya and Aspergillus

Journal: Current Drug Delivery
Volume: 13,Issue: 3
Page: 378-388
Authors: War War May Zin, Chadaporn Prompanya, Suradet Buttachon and Anake Kijjoa

Impact of PLK-1 Silencing on Endothelial Cells and Cancer Cells of Diverse Histological Origin

Journal: Current Gene Therapy
Volume: 13,Issue: 3
Page: 189-201
Authors: Carla P. Gomes, Ligia C. Gomes-da-Silva, Jose S. Ramalho, Maria C.P. de Lima, Sergio Simoes and Joao N. Moreira

Somatostatin Receptor-Targeted Anti-Cancer Therapy

Journal: Current Drug Delivery
Volume: 8,Issue: 1
Page: 2-10
Authors: Li-Chun Sun and David H. Coy

Targeting Angiogenesis for Treatment of NSCLC Brain Metastases

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 3
Page: 289-299
Authors: C. Schettino, M. A. Bareschino, A. Rossi, P. Maione, P. C. Sacco, G. Colantuoni, E. Rossi and C. Gridelli

Interferon Therapy in Lung Cancer: Current Perspectives

Journal: Current Cancer Therapy Reviews
Volume: 12,Issue: 4
Page: 237-245
Authors: Debosree Ghosh and Pratap Parida*

Cytotoxicity and Cell Death Mechanisms Induced by a Novel Bisnaphthalimidopropyl Derivative against the NCI-H460 non-small Lung Cancer Cell Line

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 3
Page: 414-421
Authors: Raquel T. Lima, Gemma A. Barron, Joanna A. Grabowska, Giovanna Bermano, Simranjeet Kaur, Nilanjan Roy, M. Helena Vasconcelos and Paul K.T. Lin

The Epidermal Growth Factor Receptor as a Therapeutic Target in Glioblastoma Multiforme and other Malignant Neoplasms

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 6
Page: 703-715
Authors: S. Loew, U. Schmidt, A. Unterberg and M.-E. Halatsch

Enteral Administration of TKIs: Report of a Response to Ceritinib in an ALK-positive NSCLC Patient and Literature Review

Journal: Current Drug Targets
Volume: 19,Issue: 0
Page: 1-8
Authors: Francesco Facchinetti, Paola Bordi*, Paola Bini, Livia Bidin, Roberta Camisa and Marcello Tiseo

Discovery of Hybrid Purine-Quinoline Molecules and Their Cytotoxic Evaluation

Journal: Letters in Drug Design & Discovery
Volume: 15,Issue: 0
Page: 1-8
Authors: Khushal M Kapadiya and Ranjan C Khunt*

Systemic Treatment of Chest Tumors: Highlighting Some Differences Between Eastern and Western Countries

Journal: Current Cancer Therapy Reviews
Volume: 14,Issue: 0
Page: 1-17
Authors: Dora LW Kwong and Lee Ho Fun Victor*

Development of Highly Efficient KinExA Immunosensor-Based Assay for the Measurement of Carcinoembryonic Antigen in Serum

Journal: Current Analytical Chemistry
Volume: 14,Issue: 0
Page: 1-6
Authors: Ibrahim Darwish*, Tanveer Wani and Mohammed Hamidaddin

TC > 0.05 as a Pharmacokinetic Parameter of Paclitaxel for Therapeutic Efficacy and Toxicity in Cancer Patients

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13,Issue: 0
Page: 1-7
Authors: D. S. Xin, L. Zhou, C. Z. Li, S. Q. Zhang, H. Q. Huang, G. D. Qiu, L. F. Lin, Y. Q. She, J. T. Zheng, C. Chen, L. Fang, Zhe-Sheng Chen* and S. Y. Zhang

Farnesyltransferase Inhibitors: A Comprehensive Review Based on Quantitative Structural Analysis

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 4888-4923
Authors: N. S.H.N. Moorthy, S. F. Sousa, M. J. Ramos and P. A. Fernandes

Role of Tyrosine Kinase Inhibitors in Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 5
Page: 569-575
Authors: J. Ansari, D. H. Palmer, D. W. Rea and S. A. Hussain

18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry

Journal: Current Radiopharmaceuticals
Volume: 10,Issue: 0
Page: 1-8
Authors: Paola Mapelli, Valentino Bettinardi, Federico Fallanca, Elena Incerti, Antonia Compierchio, Francesca Rossetti, Angela Coliva, Annarita Savi, Claudio Doglioni, Giampiero Negri, Luigi Gianolli and Maria Picchio*


Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 4
Page: 413-424
Authors: Si-Shen Feng, Li Mu, Khin Yin Win and Guofeng Huang

Development of New ELISA with High Sensitivity and Selectivity for Bioanalysis of Bevacizumab: A Monoclonal Antibody Used for Cancer Immunotherapy

Journal: Current Analytical Chemistry
Volume: 14,Issue: 2
Page: 174-181
Authors: Ibrahim A. Darwish, Mona M. Al-Shehri and Manal A. El-Gendy*

Results 1 - 227 of 227